US-based DuPont has launched Tyvek with Renewable Attribution (RA), a new addition to its portfolio of Tyvek products designed for healthcare packaging.
This product offers a significantly reduced carbon footprint, contributing to more sustainable healthcare packaging solutions.
The carbon footprint reduction is achieved through the partial replacement of fossil fuel feedstock with certified biocircular feedstock during the production of raw materials used in Tyvek manufacturing.
The mass balance approach, compliant with International Sustainability and Carbon Certification (ISCC) PLUS, facilitates this transition.
Tyvek with RA is engineered to lower the carbon footprint of healthcare products while providing a drop-in solution that can be seamlessly integrated into existing packaging systems.
DuPont has attained ISCC PLUS certification for its Tyvek facilities located in Richmond, US, and Luxembourg. This certification ensures credible measurement, tracking, and attribution of biocircular feedstocks.
The RA extension of Tyvek Healthcare Packaging products aligns with DuPont’s global strategy to promote a circular economy and collaborate with supply chains to mitigate scope 3 emissions.
DuPont vice-president and general manager David Domnisch said: “Tyvek has long been a trusted choice for helping to enable patient safety through superior microbial barrier, exceptional strength and durability, breathability, and recyclability.
“We are proud to continue this dedicated focus on product performance, quality and reliability, in a manner that now also supports the healthcare packaging industry’s efforts to advance sustainability.”
This September, DuPont committed to achieving net-zero carbon emissions by 2050, building on its progress since 2019 when the company set its Acting on Climate Goal as part of its sustainability strategy.
As disclosed in April 2024, DuPont has surpassed its climate targets, realising a 58% reduction in scopes 1 and 2 emissions from a 2019 baseline, alongside a 39% reduction in scope 3 emissions from a 2020 baseline.
In May 2023, DuPont announced the acquisition of medical device manufacturer Spectrum Plastics Group for $1.75bn.
